Adding a new natural protein in the body has found that it can prevent heart attacks and strokes
Scientists have identified a natural protein in the human body that protects against heart attacks and strokes, and it may be an important premise to help develop new therapies to prevents fat accumulation in arteries.
Specifically, researchers from King's College London in England measured a new protein level called dickkopf 3 (DKK3) in blood samples collected from 574 people in five years. They found that those with higher DKK3 levels were less likely to develop atherosclerosis or die of a heart attack or stroke .
The correlation is also related to factors similar to the risk of atherosclerosis such as high blood pressure and high cholesterol, the researchers said.
Atherosclerosis is the accumulation of fat inside arteries. When this material breaks, blood clots can form to prevent blood supply to the heart or brain, causing a heart attack or stroke.
The researchers found that mice that were cultivated because of the lack of DKK3 genetic protein had a higher risk of developing atherosclerotic plaques, which were less stable than those who could produce DKK3 protein in the body.
They also noted that mice lacking DKK3 protein were also unable to re-develop the endothelial membrane after injury.
This suggests that DKK3 can protect against atherosclerosis by helping repair broken endothelial membranes before any fat builds up.
"Our research shows that we can use a simple blood test to identify people who seem healthy and have a risk of having a heart attack and are often difficult to diagnose by a clinician. Guess that there is a high risk of disease ' - Qingbo Xu, a professor at King's College London, said in a statement.
"Finally, increasing the level of DDK3 can help protect people against the accumulation of harmful fats that cause heart attacks, strokes," Xu added.
Jeremy Perarson, a professor at the British Heart Foundation, said: "By identifying a new protective molecule, this study could be an important prerequisite for making new drugs that reduce the risk of heart attack ."
Every year in the UK there are about 200,000 hospitalizations due to heart attacks.
This study shows that it can help treat the roots of this dangerous disease and ultimately improve the survival rate.
This research has just been published in Circulation magazine.
You should read it
- How to prevent and control high blood pressure?
- High cholesterol can make arthritis worse
- Top 7 foods that help reduce blood cholesterol best
- How to reduce blood cholesterol effectively?
- High blood pressure, arthritis is more common in people living on high
- Finding new ways to study cholesterol distribution on cells
- Foods high in cholesterol: What should be eaten? What type should be avoided?
- Finding the single gene can help you avoid heart disease
May be interested
- Survivors of the 9/11 terrorist attacks are more likely to suffer from heart and lung diseaserescue workers and survivors of the 9/11 terrorist attacks at the world trade center in the us in 2001 seem to be at risk of heart and lung disease years later, according to a new study. shows.
- FDA unexpectedly approved Nerlynx therapy to reduce the risk of breast cancer recurrencefood and drug administration (fda), us has just officially approved the use of nerlynx therapy to treat early-stage her2-positive breast cancer to reduce the risk of recurrence.
- Herpes virus is similar to the human infection Epstein-Barr virus found in mountain gorillasthe researchers say the herpes virus is similar to the human infectious epstein-barr virus found in mountain gorillas.
- Obese mothers during pregnancy are related to behavioral problems in boys after birtha new study at the university of california, berkeley shows that obesity in pregnant women is associated with a higher risk of behavioral problems in boys later.
- Finding new drugs that treat breast cancer is thought to be well toleratedresearch shows that a new drug has been proven successful in treating the most common forms of breast cancer well tolerated by patients.
- Officially identified the target receptor for the treatment of neuroblastomathe researchers say they have identified a type of receptor called protein-tyrosine z phosphatase, or ptprz as a potential drug target for patients with glioblastoma.